Assessment of the Impact of Probiotics on Biofilm Formation on Removable Acrylic Dentures

April 7, 2016 updated by: Universitaire Ziekenhuizen KU Leuven
The aim of this study is to evaluate the effect of PIP toothbrush cleaner® on the microbial composition and Candida albicans colonization of denture biofilm formation. Additionally, its effect will be compared to that of cleansing tablets.

Study Overview

Detailed Description

Therefore the present study intended to compare a probiotic denture cleaning protocol with the current protocols. It was aimed to examine, in institutionalized older individuals with removable complete dentures, if the microbial composition and C. albicans colonization of the denture biofilm differs when overnight stored in a probiotic cleaning product compared to water or a cleanser. Additionally the influence of brushing on these protocols was investigated.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • Department of Oral Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Reside in a home for elderly
  • Fully edentulous in lower and upper jaw
  • Removable denture wearer in lower and upper jaw
  • Good oral health

Exclusion Criteria:

  • Current or history of corticosteroid treatment within the 3 months prior to the study
  • Current or history of antimicrobial treatment within the 3 months prior to the study
  • Inability to provide informed consent
  • Inability to comply with the study requirements
  • Heart disorders persons with a high risk for an unfavourable prognosis of bacterial endocarditis will be excluded. This applies to patients with prosthetic heart valves, history of infectious endocarditis, cyanogenic congenital heart disorders (including palliative shunts and connections), completely recovered congenital disorders that were treated less than 6 months ago, treated congenital heart disorders with residual defect, and valvulopathy after heart transplantation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Immersion in water
water
Water
Active Comparator: Immersion in water + cleansing tablet
Corega Tabs Anti-bacteria® (GlaxoSmithKline Consumer Healthcare SA, Genval, Belgium)
Cleansing tablet -Corega Tabs Anti-bacteria® (GlaxoSmithKline Consumer Healthcare SA, Genval, Belgium)
Other Names:
  • Cleansing tablet
Experimental: Immersion in water with PIP
PIP toothbrush cleaner® (Chrisal, Lommel, Belgium)
Probiotic
Other Names:
  • Probiotic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Candida albicans colonization
Time Frame: day 5
C. albicans colonization was the primary outcome measure of interest. With a microbial test there was researched if C. albicans colonized the prostheses.
day 5

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Other microbiological counts Aa
Time Frame: day 5
The concentration of Aggregatibacter Actinomycetemcomitans was researched.
day 5
Other microbiological counts Pg
Time Frame: day 5
The concentration of Porphyromonas gingivalis was researched.
day 5
Other microbiological counts Tf
Time Frame: day 5
The concentration of Tannerella forsythensis was researched.
day 5
Other microbiological counts Td
Time Frame: day 5
The concentration of Treponema denticola was researched.
day 5
Other microbiological counts Pi
Time Frame: day 5
The concentration of Prevotella intermedia was researched.
day 5
Other microbiological counts Fn
Time Frame: day 5
The concentration of Fusobacterium nucleatum was researched.
day 5
Other microbiological counts Pm
Time Frame: day 5
The concentration of Peptostreptococcus micros was researched.
day 5
Other microbiological counts Pn
Time Frame: day 5
The concentration of Prevotella nigrescens was researched.
day 5
Other microbiological counts Cg
Time Frame: day 5
The concentration of Campylobacter gracilis was researched.
day 5
Other microbiological counts Cr
Time Frame: day 5
The concentration of Campylobacter rectus was researched.
day 5
Other microbiological counts En
Time Frame: day 5
The concentration of Eubacterium nodatum was researched.
day 5
Other microbiological counts Ec
Time Frame: day 5
The concentration of Eikenella corrodens was researched.
day 5
Other microbiological counts Capn
Time Frame: day 5
The concentration of Capnocytophaga species was researched.
day 5
Other microbiological counts Cc
Time Frame: day 5
The concentration of Campylobacter concisus count was researched.
day 5
Other microbiological counts mitis streptococci
Time Frame: day 5
Concentration of mitis streptococci
day 5
Other microbiological counts Sg
Time Frame: day 5
The concentration of Streptococcus gordonii
day 5
Other microbiological counts Sc
Time Frame: day 5
The concentration of Streptococcus constellatus.
day 5
Other microbiological counts Ao
Time Frame: day 5
The concentration of Actinomyces odontolyticus.
day 5
Other microbiological counts Av
Time Frame: day 5
The concentration of Actinomyces viscosus.
day 5
Other microbiological counts Vp
Time Frame: day 5
The concentration of Veillonella parvula.
day 5
Other microbiological counts total
Time Frame: day 5
Total bacterial count.
day 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Joke Duyck, DDS, PhD, Universitaire Ziekenhuizen KU Leuven

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

January 17, 2014

First Submitted That Met QC Criteria

April 7, 2016

First Posted (Estimate)

April 13, 2016

Study Record Updates

Last Update Posted (Estimate)

April 13, 2016

Last Update Submitted That Met QC Criteria

April 7, 2016

Last Verified

November 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • S56279

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mandibular Prosthesis User

Clinical Trials on Water

Subscribe